Aug. 11, 2014 /PRNewswire/ --Rock Creek Pharmaceuticals, Inc., (NASDAQ: RCPI), a drug development company focused ... program in the United Kingdom under a Clinical Trial Application (CTA) currently anticipated to be filed by the end of the third quarter . ... ...

32 people liked this